Search
Astrana Health Inc
ASTHAdd to Watchlist
35.560USD
-1.120-3.05%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.76BMarket Cap
57.76P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Astrana Health Inc is 8.55, ranking 13 out of 75 in the Healthcare Providers & Services industry. The average price target is 38.50, with a high of 54.00 and a low of 26.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
47.667
Target Price
+34.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
Astrana Health Inc
ASTH
11
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Astrana Health Inc's expected revenue for the next quarter?
Astrana Health Inc's expected revenue is 985.72M.
What is Astrana Health Inc's price target?
Analysts forecast that Astrana Health Inc's price target is USD 38.50, with the highest forecast at USD 54.00 and the lowest forecast at USD 26.00.
How have Astrana Health IncASTH's recent earnings per share performed?
The market expectation was USD 0.30, while Astrana Health IncASTH's earnings per share (EPS) for the previous quarter was USD 0.12. EPS for the next quarter is expected at USD 0.34.
What is the analyst rating for Astrana Health Inc?
Based on the ratings of Astrana Health Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.